Source: Annual Congress 2006 - Diagnosis of tuberculosis infection and immunology of tuberculosis
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
A. Guzel, P. Yildiz, G. Deniz, G. Yillar, V. Yilmaz (Istanbul, Turkey). Serum leptin, insulin and C-reactive protein (CRP) in patients with pulmonary tuberculosis. Eur Respir J 2006; 28: Suppl. 50, 2052

Member's Comments

No comment yet.

Related content which might interest you: The relation of serum interleukin-6 and C-reactive protein to clinical parameters in pulmonary tuberculosis Source: Eur Respir J 2004; 24: Suppl. 48, 35s Year: 2004 Levels of serum amyloid A (SAA) and C-reactive protein (CRP) in stable COPD patients and its relationship with disease severity. Source: International Congress 2017 – COPD biomarkers Year: 2017 Usefulness of serum procalcitonin in lung cancer patients with elevated serum C-reactive protein level Source: Annual Congress 2011 - Instructive clinical aspects of lung cancer Year: 2011 The association of C-reactive protein, serum amyloid-A and fibrinogen with prevalent asthma Source: Eur Respir J 2001; 18: Suppl. 33, 506s Year: 2001 Level of C-reactive protein in blood serum of patients with MDR tuberculosis before and after treatment Source: Eur Respir J 2007; 30: Suppl. 51, 201s Year: 2007 D-dimer to C-reactive protein (CRP) ratio in patients with suspected pulmonary embolism Source: Annual Congress 2010 - Pulmonary embolism Year: 2010 C-reactive protein in pulmonary TB Source: Annual Congress 2009 - Diagnostic advances in tuberculosis Year: 2009 Determinants of serum leptin and adiponectin levels in patients with COPD Source: Eur Respir J 2005; 26: Suppl. 49, 59s Year: 2005 Is there a relationship between severity of COPD and C-reactive protein (CRP) levels? Source: Eur Respir J 2006; 28: Suppl. 50, 37s Year: 2006 Changes in levels of inflammatory markers (procalcitonin, C-reactive protein) in pregnant with community-acquired pneumonia (CAP) Source: International Congress 2016 – Community-acquired pneumonia: risk classes and management issues Year: 2016 Serum C-reactive protein concentrations in patients with sarcoidosis: can be taken this simple test as an activation marker in sarcoidosis? Source: Eur Respir J 2004; 24: Suppl. 48, 712s Year: 2004 Serum neopterin and IL-6 as biomarkers in patients with COPD. Source: International Congress 2017 – Novel molecular and genetic targets in COPD Year: 2017 High sensitivity C-reactive protein in asthma Source: Eur Respir J 2006; 27: 908-912 Year: 2006 The relationship between level of C-reactive protein in blood serum and clinical manifestations of the disease in patients with pulmonary tuberculosis Source: Annual Congress 2010 - Tuberculosis: metabolic insights Year: 2010 Role of serum adiponectin in COPD Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD Year: 2008 Serum C-reactive protein (CRP) as a marker of the severity and prognosis of ventilator-associated pneumonia (VAP) Source: Annual Congress 2007 - Diagnostic markers and therapy in hospital-acquired pneumonia Year: 2007 Procalcitonin and C-reactive protein levels in HIV-positive subjects with tuberculosis and pneumonia Source: Eur Respir J 2005; 25: 688-692 Year: 2005 C-reactive protein (CRP) at admission: is it really usefull in COVID-19 pneumonia? Source: Virtual Congress 2021 – COVID - 19 biomarkers Year: 2021 High serum procalcitonin and C-reactive protein levels can exclude tuberculosis in community-acquired pneumonia patients with atypical presentation Source: Annual Congress 2010 - Aetiology of lower respiratory tract infections and treatment in special situations Year: 2010 Diagnostic accuracy of lipopolysaccharide-binding protein (LBP), fibrinogen and C-reactive protein (CRP) in differentiating pneumonia from acute bronchitis in primary care Source: Annual Congress 2008 - Wider aspects of managing respiratory disease in primary care Year: 2008